Showing results (211-220 of 295) with videos related to

Sort By:
Pageof 30
Clinical Neurology and Neurosurgery|September 17, 2013
Clinical and radiological impact of liver transplantation for brain in cirrhosis patients without hepatic encephalopathyTetsuro Ishihara, Mizuki Ito, Yoshiki Niimi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 30, 2013
Pegylated interferon monotherapy in patients with chronic hepatitis C with low viremia and its relationship to mutations in the NS5A region and the single nucleotide polymorphism of interleukin-28BKazuhiko Hayashi, Yoshiaki Katano, Hiroko Masuda, et al.
Journal of Digestive Diseases|January 13, 2025
Type 2 Diabetes and Hypertension as Risk Factors for Advanced Fibrosis in Biopsy Proven Metabolic Dysfunction-Associated Steatotic Liver DiseaseYosuke Inukai, Takanori Ito, Shinya Yokoyama, et al.
Nagoya Journal of Medical Science|December 22, 2022
Analysis of immunologic comorbidities in ulcerative colitis patients: a tool to prevent exacerbations in ulcerative colitis casesMiguel Ricardo Rodríguez Meza, Masanao Nakamura, Takeshi Yamamura, et al.
Digestive Diseases (Basel, Switzerland)|February 2, 2022
Factors Related to Delayed Adverse Events of Endoscopic Submucosal Dissection in the DuodenumTatsuya Kawamura, Takashi Hirose, Naomi Kakushima, et al.
Journal of Gastroenterology and Hepatology|August 6, 2014
Effect of peginterferon alfa-2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis CTakashi Honda, Masatoshi Ishigami, Hiroko Masuda, et al.
Journal of Gastroenterology|March 29, 2023
Serum osteopontin predicts the response to atezolizumab plus bevacizumab in patients with hepatocellular carcinomaReika Yamauchi, Takanori Ito, Sachiyo Yoshio, et al.
Biochemical and Biophysical Research Communications|June 11, 2008
Regulation of branched-chain amino acid catabolism in rat models for spontaneous type 2 diabetes mellitusTeiji Kuzuya, Yoshiaki Katano, Isao Nakano, et al.
Pageof 30